LINCOLN POLICY GROUP for FRESENIUS MEDICAL CARE NORTH AMERICA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 21, 2020 | $50,000 | Replaced |
| 4th Quarter - Amendment | Apr 24, 2020 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| RUDY MISSMAR | — |
| COLIN ROSKEY New | Health Policy Advisor and Counsel, Senate Finance Committee |
| THOMAS A SCULLY | — |
| REGINA MARIA SHERICK | — |
Health Issues HCR
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| RUDY MISSMAR | — |
| COLIN ROSKEY New | Health Policy Advisor and Counsel, Senate Finance Committee |
| THOMAS A SCULLY | — |
| REGINA MARIA SHERICK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.